...
首页> 外文期刊>Advances in cancer research. >Innate immune recognition and suppression of tumors.
【24h】

Innate immune recognition and suppression of tumors.

机译:先天免疫识别和抑制肿瘤。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this chapter, we first summarized the strong evidence that now supports the existence of an effective cancer immune surveillance process that prevents cancer development in both mice and humans. We then focused the remainder of the chapter on methods of tumor recognition that contribute to natural host immune suppression of tumors. In particular, NKG2D is a type II transmembrane-anchored glycoprotein expressed as a disulfide-linked homodimer on the surface of all mouse and human natural killer cells (NK cells). Stimulation of NK cell through NKG2D triggers cell-mediated cytotoxicity and in some cases induces production of cytokines. NKG2D binds to family of ligands with structural homology to major histocompatibility complex (MHC) class I, however, NKG2D ligands often display upregulated surface expression on stressed cells and are frequently overexpressed by tumors unlike conventional MHC class I molecules. Evidence clearly implicate that NKG2D recognition plays an important role in tumor immune surveillance.
机译:在本章中,我们首先总结了有力的证据,这些证据现在支持有效的癌症免疫监视过程的存在,该过程可防止小鼠和人类患癌症。然后,我们将本章的其余部分集中于有助于自然抑制宿主免疫肿瘤的肿瘤识别方法。特别地,NKG2D是II型跨膜锚定的糖蛋白,在所有小鼠和人类自然杀伤细胞(NK细胞)的表面上均表现为二硫键连接的同型二聚体。通过NKG2D刺激NK细胞会触发细胞介导的细胞毒性,在某些情况下会诱导细胞因子的产生。 NKG2D结合具有与I类主要组织相容性复合物(MHC)的结构同源性的配体家族,但是,与传统的I类MHC分子不同,NKG2D配体通常在应激细胞上显示出上调的表面表达,并经常被肿瘤过度表达。有证据明确表明,NKG2D识别在肿瘤免疫监测中起着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号